AKT1 and obesity disorder: Furthermore, due to damage to AKT1 signaling pathways, insulin cannot be effectively transported to the vascular system by the action of endothelial nitric oxide synthase (eNOS), leading to obesity and insulin resistance, followed by artery dysfunction and hypertension (30, 31).